Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,822 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,088 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02474186 | Phase II Study for Solid Metastatic Tumors | completed | Phase 2 | 41 | NYU Langone HealthOTHER | 0 | Aug 3, 2017 | clinicaltrials |
| NCT01928940 | Japan PhI/II of GSK2118436 and GSK1120212 Combination in Subjects With BRAF V600E/K Mutation Positive Advanced Solid Tumors (Phase I Part) or Cutaneous Melanoma (Phase II Part) | completed | Phase 2 | 12 | GlaxoSmithKlineINDUSTRY | 1 | Jul 24, 2017 | clinicaltrials |
| NCT02205333 | A Phase 1b/2 Safety and Tolerability Study of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies(MEDI6469) | terminated | Phase 1 / Phase 2 | 48 | MedImmune LLCINDUSTRY | 1 | Jun 28, 2017 | clinicaltrials |
| NCT03182803 | CTLA-4 and PD-1 Antibodies Expressing Mesothelin-CAR-T Cells for Mesothelin Positive Advanced Solid Tumor | unknown | Phase 1 / Phase 2 | 40 | Shanghai Cell Therapy Research InstituteOTHER | 1 | Jun 9, 2017 | clinicaltrials |
| NCT03182816 | CTLA-4 and PD-1 Antibodies Expressing EGFR-CAR-T Cells for EGFR Positive Advanced Solid Tumor | unknown | Phase 1 / Phase 2 | 40 | Shanghai Cell Therapy Research InstituteOTHER | 1 | Jun 9, 2017 | clinicaltrials |
| NCT03179007 | CTLA-4 and PD-1 Antibodies Expressing MUC1-CAR-T Cells for MUC1 Positive Advanced Solid Tumor | unknown | Phase 1 / Phase 2 | 40 | Shanghai Cell Therapy Research InstituteOTHER | 1 | Jun 7, 2017 | clinicaltrials |
| NCT03171220 | Neoantigen Reactive T Cells Combined With SHR-1210 for Chinese Patients With Advanced Refractory Solid Tumors(NRT-01) | unknown | Phase 1 / Phase 2 | 40 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Jun 6, 2017 | clinicaltrials |
| NCT02766842 | Evaluation of a New EUS Guided Biopsy Needle (SharkCore) Comparing to Standard EUS Needle (ProCore) | withdrawn | Phase 2 | 0 | Johns Hopkins UniversityOTHER | 1 | May 15, 2017 | clinicaltrials |
| NCT00335478 | Daptomycin in Treating Neutropenia and Fever in Patients With Cancer | completed | Phase 2 | 54 | OHSU Knight Cancer InstituteOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT01031953 | Fosaprepitant Dimeglumine in Treating Patients With Nausea and Vomiting Caused By Chemotherapy | terminated | Phase 1 / Phase 2 | 34 | OHSU Knight Cancer InstituteOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT00408499 | Erlotinib and Cetuximab in Treating Patients With Advanced Solid Tumors With Emphasis on Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 64 | University of California, DavisOTHER | 1 | May 8, 2017 | clinicaltrials |
| NCT00004005 | Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin | completed | Phase 2 | 12 | St. Jude Children's Research HospitalOTHER | 1 | Apr 26, 2017 | clinicaltrials |
| NCT01240590 | A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC) | completed | Phase 1 / Phase 2 | 27 | National Cancer Institute (NCI)NIH | 1 | Apr 10, 2017 | clinicaltrials |
| NCT00952848 | Electrical Stimulation Therapy Using the MC5-A Scrambler in Reducing Peripheral Neuropathy Caused by Chemotherapy | completed | Phase 2 | 18 | Virginia Commonwealth UniversityOTHER | 0 | Mar 29, 2017 | clinicaltrials |
| NCT00311597 | Extracranial Stereotactic Radiosurgery in Treating Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 48 | Wake Forest University Health SciencesOTHER | 1 | Mar 14, 2017 | clinicaltrials |
| NCT02449538 | Study to Evaluate the Safety and Efficacy of Everolimus, in Subjects With PIK3CA Amplification, PTEN Loss and PIK3CA Mutation Refractory Solid Tumors | completed | Phase 2 | 10 | Samsung Medical CenterOTHER | 1 | Feb 17, 2017 | clinicaltrials |
| NCT02890511 | A Study DHP107, a Novel Oral Paclitaxel Formulation, in Patients With Advanced Solid Tumours or Gastric Cancer | completed | Phase 1 / Phase 2 | 28 | Daehwa Pharmaceutical Co., Ltd.INDUSTRY | 1 | Feb 13, 2017 | clinicaltrials |
| NCT00416624 | Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy | completed | Phase 2 | 239 | Mayo ClinicOTHER | 1 | Feb 10, 2017 | clinicaltrials |
| NCT00585221 | Study of Imatinib and Peginterferon α-2b in Gastrointestinal Stromal Tumor (GIST) Patients | terminated | Phase 2 | 8 | University of UtahOTHER | 1 | Feb 10, 2017 | clinicaltrials |
| NCT00019604 | Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer | terminated | Phase 2 | 44 | National Institutes of Health Clinical Center (CC)NIH | 1 | Feb 3, 2017 | clinicaltrials |
| NCT03030001 | PD-1 Antibody Expressing CAR T Cells for Mesothelin Positive Advanced Malignancies | unknown | Phase 1 / Phase 2 | 40 | Ningbo Cancer HospitalINDUSTRY | 1 | Jan 24, 2017 | clinicaltrials |
| NCT00003657 | High-dose ICE With Amifostine | completed | Phase 2 | 24 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 20, 2017 | clinicaltrials |
| NCT00550654 | Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain | terminated | Phase 2 | 1 | National Institutes of Health Clinical Center (CC)NIH | 1 | Jan 13, 2017 | clinicaltrials |
| NCT01611857 | Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach | completed | Phase 1 / Phase 2 | 49 | SCRI Development Innovations, LLCOTHER | 1 | Nov 23, 2016 | clinicaltrials |
| NCT00064272 | UMCCOP 02-01 Ginger in Treating Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer(IRB 2003-551) | completed | Phase 2 | 180 | University of Michigan Rogel Cancer CenterOTHER | 2 | Oct 21, 2016 | clinicaltrials |
| NCT02862028 | PD-1 Antibody Expressing CAR-T Cells for EGFR Family Member Positive Advanced Solid Tumor (Lung, Liver and Stomach) | unknown | Phase 1 / Phase 2 | 20 | Shanghai International Medical CenterINDUSTRY | 1 | Aug 25, 2016 | clinicaltrials |
| NCT02844881 | Study of Apatinib and MASCT in Patients With Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 60 | The First People's Hospital of LianyungangOTHER | 1 | Aug 11, 2016 | clinicaltrials |
| NCT02858232 | MASCT-I Treatment for Advanced Solid Tumor | unknown | Phase 1 / Phase 2 | 46 | The First People's Hospital of LianyungangOTHER | 0 | Aug 11, 2016 | clinicaltrials |
| NCT01624467 | A Study of Necitumumab Monotherapy and the QT/QTc Interval in Patient With Advanced Solid Tumors | completed | Phase 2 | 75 | Eli Lilly and CompanyINDUSTRY | 1 | Jul 25, 2016 | clinicaltrials |
| NCT00003130 | Paclitaxel in Treating Women With Recurrent Solid Tumors | completed | Phase 2 | 32 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 19, 2016 | clinicaltrials |
| NCT00003565 | Docetaxel in Treating Patients With Solid Tumors | completed | Phase 2 | 109 | Alliance for Clinical Trials in OncologyOTHER | 3 | Jul 14, 2016 | clinicaltrials |
| NCT02656849 | BAY 1000394 for MCL-1-, MYC-, and CCNE1-Amplified Tumors | withdrawn | Phase 2 | 0 | Dana-Farber Cancer InstituteOTHER | 1 | Jul 1, 2016 | clinicaltrials |
| NCT00578942 | Allo Non-myeloablative SCT Utilizing Matched Family Member Stem Cells Purged Using Campath | completed | Phase 2 | 48 | David Rizzieri, MDOTHER | 1 | Jun 24, 2016 | clinicaltrials |
| NCT01803503 | Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors | unknown | Phase 2 | 80 | National University Hospital, SingaporeOTHER | 1 | Jun 22, 2016 | clinicaltrials |
| NCT01008904 | Magnesium Oxide in Treating Hot Flashes in Menopausal Women With Cancer | completed | Phase 2 | 31 | Virginia Commonwealth UniversityOTHER | 0 | Jun 21, 2016 | clinicaltrials |
| NCT00938457 | Stereotactic Radiation Therapy in Treating Patients With Liver Metastases | terminated | Phase 1 / Phase 2 | 3 | Mayo ClinicOTHER | 1 | May 19, 2016 | clinicaltrials |
| NCT01461538 | Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies | completed | Phase 2 | 84 | Seagen Inc.INDUSTRY | 1 | Mar 4, 2016 | clinicaltrials |
| NCT01844661 | Safety and Efficacy of Repeated Infusion of CELYVIR in Children and Adults With Metastatic and Refractory Tumors. | completed | Phase 1 / Phase 2 | 20 | Hospital Infantil Universitario Niño Jesús, Madrid, SpainOTHER | 1 | Feb 19, 2016 | clinicaltrials |
| NCT01799083 | Lower Dose Decitabine Based Therapy in Patients With Refractory and/or Chemotherapy Resistant Solid Tumors or B Cell Lymphomas(CIK) | unknown | Phase 1 / Phase 2 | 100 | Han weidongOTHER | 1 | Jan 28, 2016 | clinicaltrials |
| NCT00888134 | Selumetinib in Cancers With BRAF Mutations | completed | Phase 2 | 28 | National Cancer Institute (NCI)NIH | 1 | Jan 15, 2016 | clinicaltrials |
| NCT00082290 | Massage Therapy in Treating Patients With Cancer Pain | completed | Phase 2 | 92 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 18, 2015 | clinicaltrials |
| NCT00053846 | Buspirone in Reducing Shortness of Breath in Patients With Cancer | completed | Phase 2 / Phase 3 | 432 | University of RochesterOTHER | 1 | Nov 24, 2015 | clinicaltrials |
| NCT00982657 | A Trial Of CVX-060, An Anti-Angiogenic COVX-Body, In Combination With Sunitinib In Patients With Advanced Renal Cell Carcinoma | terminated | Phase 2 | 34 | PfizerINDUSTRY | 1 | Nov 20, 2015 | clinicaltrials |
| NCT00773344 | Clinical Trial of the Combination of Trastuzumab (Herceptin) and Tanespimycin in Patients With Solid Tumors and Her2 Positive Metastatic Breast Cancer That Have Previously Failed Herceptin | completed | Phase 1 / Phase 2 | 25 | Bristol-Myers SquibbINDUSTRY | 1 | Nov 4, 2015 | clinicaltrials |
| NCT00704938 | Gene-Modified Lymphocytes, High-Dose Aldesleukin, and Vaccine Therapy in Treating Patients With Progressive or Recurrent Metastatic Cancer | terminated | Phase 2 | 3 | National Institutes of Health Clinical Center (CC)NIH | 1 | Oct 28, 2015 | clinicaltrials |
| NCT01100931 | A Phase I/II Study of Paclitaxel, Carboplatin and YM155 (Survivin Suppressor) in Subjects With Solid Tumors (Phase I) and Advanced Non-Small Cell Lung Carcinoma (Phase II) | completed | Phase 1 / Phase 2 | 42 | National Cancer Institute (NCI)NIH | 1 | Oct 19, 2015 | clinicaltrials |
| NCT00003817 | Acupressure and Acustimulation Wrist Bands for the Prevention of Nausea and Vomiting Caused by Chemotherapy | completed | Phase 2 | 700 | Gary MorrowOTHER | 1 | Oct 15, 2015 | clinicaltrials |
| NCT00360867 | An Open Label Treatment Extension Study of AMG 706 | terminated | Phase 2 | 94 | AmgenINDUSTRY | 0 | Oct 15, 2015 | clinicaltrials |
| NCT00546247 | A Phase 1/2 Study of Epofolate (BMS-753493) in Subjects With Advanced Cancer (Schedule 1) | terminated | Phase 1 / Phase 2 | 26 | Bristol-Myers SquibbINDUSTRY | 2 | Oct 12, 2015 | clinicaltrials |
| NCT00550017 | A Phase 1/2 Study of Epofolate (BMS-753493) in Subjects With Advanced Cancer (Schedule 2) | terminated | Phase 1 / Phase 2 | 39 | Bristol-Myers SquibbINDUSTRY | 3 | Oct 12, 2015 | clinicaltrials |
Data updated 22 days agoSource updated Aug 3, 2017source: clinicaltrials